METTLER-TOLEDO INTERNATIONAL (MTD) Stock Fundamental Analysis

NYSE:MTD • US5926881054

1376.53 USD
+0.96 (+0.07%)
At close: Feb 19, 2026
1376.53 USD
0 (0%)
After Hours: 2/19/2026, 8:18:19 PM
Fundamental Rating

5

MTD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. While MTD has a great profitability rating, there are some minor concerns on its financial health. MTD has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • MTD had positive earnings in the past year.
  • In the past year MTD had a positive cash flow from operations.
  • In the past 5 years MTD has always been profitable.
  • MTD had a positive operating cash flow in each of the past 5 years.
MTD Yearly Net Income VS EBIT VS OCF VS FCFMTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • MTD's Return On Assets of 23.41% is amongst the best of the industry. MTD outperforms 100.00% of its industry peers.
  • MTD's Return On Invested Capital of 37.49% is amongst the best of the industry. MTD outperforms 98.28% of its industry peers.
  • MTD had an Average Return On Invested Capital over the past 3 years of 41.42%. This is significantly above the industry average of 12.04%.
Industry RankSector Rank
ROA 23.41%
ROE N/A
ROIC 37.49%
ROA(3y)24.52%
ROA(5y)24.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.42%
ROIC(5y)40.53%
MTD Yearly ROA, ROE, ROICMTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2K -2K

1.3 Margins

  • The Profit Margin of MTD (21.59%) is better than 98.28% of its industry peers.
  • MTD's Profit Margin has improved in the last couple of years.
  • MTD's Operating Margin of 28.20% is amongst the best of the industry. MTD outperforms 98.28% of its industry peers.
  • In the last couple of years the Operating Margin of MTD has grown nicely.
  • MTD has a Gross Margin of 59.37%. This is in the better half of the industry: MTD outperforms 79.31% of its industry peers.
  • MTD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 28.2%
PM (TTM) 21.59%
GM 59.37%
OM growth 3Y-0.93%
OM growth 5Y1.75%
PM growth 3Y-1.02%
PM growth 5Y2.02%
GM growth 3Y0.28%
GM growth 5Y0.34%
MTD Yearly Profit, Operating, Gross MarginsMTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

4

2. Health

2.1 Basic Checks

  • MTD has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • Compared to 1 year ago, MTD has less shares outstanding
  • Compared to 5 years ago, MTD has less shares outstanding
  • MTD has a better debt/assets ratio than last year.
MTD Yearly Shares OutstandingMTD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
MTD Yearly Total Debt VS Total AssetsMTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • The Debt to FCF ratio of MTD is 2.54, which is a good value as it means it would take MTD, 2.54 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of MTD (2.54) is better than 86.21% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.54
Altman-Z N/A
ROIC/WACC3.47
WACC10.81%
MTD Yearly LT Debt VS Equity VS FCFMTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.14 indicates that MTD should not have too much problems paying its short term obligations.
  • The Current ratio of MTD (1.14) is worse than 81.03% of its industry peers.
  • MTD has a Quick Ratio of 1.14. This is a bad value and indicates that MTD is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.81, MTD is doing worse than 87.93% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.81
MTD Yearly Current Assets VS Current LiabilitesMTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • MTD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.96%.
  • The Earnings Per Share has been growing by 10.85% on average over the past years. This is quite good.
  • MTD shows a small growth in Revenue. In the last year, the Revenue has grown by 3.98%.
  • MTD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.47% yearly.
EPS 1Y (TTM)3.96%
EPS 3Y2.67%
EPS 5Y10.85%
EPS Q2Q%7.66%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y0.9%
Revenue growth 5Y5.47%
Sales Q2Q%8.1%

3.2 Future

  • The Earnings Per Share is expected to grow by 10.89% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 5.14% on average over the next years.
EPS Next Y8.04%
EPS Next 2Y9.41%
EPS Next 3Y10.54%
EPS Next 5Y10.89%
Revenue Next Year4.8%
Revenue Next 2Y4.76%
Revenue Next 3Y4.85%
Revenue Next 5Y5.14%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MTD Yearly Revenue VS EstimatesMTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B 4B 5B
MTD Yearly EPS VS EstimatesMTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20 40 60 80

4

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 32.17, MTD can be considered very expensive at the moment.
  • MTD's Price/Earnings ratio is a bit cheaper when compared to the industry. MTD is cheaper than 60.34% of the companies in the same industry.
  • MTD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.09.
  • MTD is valuated quite expensively with a Price/Forward Earnings ratio of 29.78.
  • 62.07% of the companies in the same industry are more expensive than MTD, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 27.98. MTD is around the same levels.
Industry RankSector Rank
PE 32.17
Fwd PE 29.78
MTD Price Earnings VS Forward Price EarningsMTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, MTD is valued a bit cheaper than the industry average as 60.34% of the companies are valued more expensively.
  • MTD's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. MTD is cheaper than 68.97% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.98
EV/EBITDA 23.85
MTD Per share dataMTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 -50 100 150

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MTD does not grow enough to justify the current Price/Earnings ratio.
  • MTD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4
PEG (5Y)2.97
EPS Next 2Y9.41%
EPS Next 3Y10.54%

0

5. Dividend

5.1 Amount

  • MTD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

METTLER-TOLEDO INTERNATIONAL

NYSE:MTD (2/19/2026, 8:18:19 PM)

After market: 1376.53 0 (0%)

1376.53

+0.96 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-05
Earnings (Next)04-29
Inst Owners103.22%
Inst Owner Change-0.32%
Ins Owners0.43%
Ins Owner Change3.33%
Market Cap27.98B
Revenue(TTM)4.03B
Net Income(TTM)869.19M
Analysts72.38
Price Target1535.88 (11.58%)
Short Float %2.66%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.56%
Min EPS beat(2)3.34%
Max EPS beat(2)3.78%
EPS beat(4)4
Avg EPS beat(4)3.47%
Min EPS beat(4)2.78%
Max EPS beat(4)3.98%
EPS beat(8)8
Avg EPS beat(8)5.09%
EPS beat(12)10
Avg EPS beat(12)2.81%
EPS beat(16)14
Avg EPS beat(16)3.29%
Revenue beat(2)2
Avg Revenue beat(2)1.74%
Min Revenue beat(2)1.23%
Max Revenue beat(2)2.25%
Revenue beat(4)3
Avg Revenue beat(4)1.23%
Min Revenue beat(4)-0.18%
Max Revenue beat(4)2.25%
Revenue beat(8)7
Avg Revenue beat(8)1.58%
Revenue beat(12)8
Avg Revenue beat(12)0.39%
Revenue beat(16)12
Avg Revenue beat(16)0.67%
PT rev (1m)0.86%
PT rev (3m)14.03%
EPS NQ rev (1m)-2.28%
EPS NQ rev (3m)-5.88%
EPS NY rev (1m)0.56%
EPS NY rev (3m)-0.53%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)1.99%
Revenue NY rev (1m)0.07%
Revenue NY rev (3m)1.56%
Valuation
Industry RankSector Rank
PE 32.17
Fwd PE 29.78
P/S 6.95
P/FCF 32.98
P/OCF 29.28
P/B N/A
P/tB N/A
EV/EBITDA 23.85
EPS(TTM)42.79
EY3.11%
EPS(NY)46.23
Fwd EY3.36%
FCF(TTM)41.74
FCFY3.03%
OCF(TTM)47.01
OCFY3.42%
SpS198.05
BVpS-1.16
TBVpS-51.24
PEG (NY)4
PEG (5Y)2.97
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 23.41%
ROE N/A
ROCE 45.15%
ROIC 37.49%
ROICexc 38.52%
ROICexgc 65.95%
OM 28.2%
PM (TTM) 21.59%
GM 59.37%
FCFM 21.08%
ROA(3y)24.52%
ROA(5y)24.33%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)41.42%
ROIC(5y)40.53%
ROICexc(3y)42.66%
ROICexc(5y)41.98%
ROICexgc(3y)76.93%
ROICexgc(5y)75.65%
ROCE(3y)49.88%
ROCE(5y)48.8%
ROICexgc growth 3Y-3.59%
ROICexgc growth 5Y2.43%
ROICexc growth 3Y-2.82%
ROICexc growth 5Y1.79%
OM growth 3Y-0.93%
OM growth 5Y1.75%
PM growth 3Y-1.02%
PM growth 5Y2.02%
GM growth 3Y0.28%
GM growth 5Y0.34%
F-Score6
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.54
Debt/EBITDA 1.66
Cap/Depr 85.28%
Cap/Sales 2.66%
Interest Coverage 250
Cash Conversion 75.8%
Profit Quality 97.64%
Current Ratio 1.14
Quick Ratio 0.81
Altman-Z N/A
F-Score6
WACC10.81%
ROIC/WACC3.47
Cap/Depr(3y)85.51%
Cap/Depr(5y)92.66%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.82%
Profit Quality(3y)102.3%
Profit Quality(5y)99.13%
High Growth Momentum
Growth
EPS 1Y (TTM)3.96%
EPS 3Y2.67%
EPS 5Y10.85%
EPS Q2Q%7.66%
EPS Next Y8.04%
EPS Next 2Y9.41%
EPS Next 3Y10.54%
EPS Next 5Y10.89%
Revenue 1Y (TTM)3.98%
Revenue growth 3Y0.9%
Revenue growth 5Y5.47%
Sales Q2Q%8.1%
Revenue Next Year4.8%
Revenue Next 2Y4.76%
Revenue Next 3Y4.85%
Revenue Next 5Y5.14%
EBIT growth 1Y0.3%
EBIT growth 3Y-0.04%
EBIT growth 5Y7.31%
EBIT Next Year13.48%
EBIT Next 3Y9.32%
EBIT Next 5Y8.58%
FCF growth 1Y-1.83%
FCF growth 3Y4.77%
FCF growth 5Y6.07%
OCF growth 1Y-1.3%
OCF growth 3Y3.62%
OCF growth 5Y5.69%

METTLER-TOLEDO INTERNATIONAL / MTD FAQ

What is the fundamental rating for MTD stock?

ChartMill assigns a fundamental rating of 5 / 10 to MTD.


What is the valuation status of METTLER-TOLEDO INTERNATIONAL (MTD) stock?

ChartMill assigns a valuation rating of 4 / 10 to METTLER-TOLEDO INTERNATIONAL (MTD). This can be considered as Fairly Valued.


Can you provide the profitability details for METTLER-TOLEDO INTERNATIONAL?

METTLER-TOLEDO INTERNATIONAL (MTD) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for MTD stock?

The Price/Earnings (PE) ratio for METTLER-TOLEDO INTERNATIONAL (MTD) is 32.17 and the Price/Book (PB) ratio is -1183.99.


Can you provide the expected EPS growth for MTD stock?

The Earnings per Share (EPS) of METTLER-TOLEDO INTERNATIONAL (MTD) is expected to grow by 8.04% in the next year.